A share price of Centessa Pharmaceuticals plc ADR [CNTA] is currently trading at $13.0, up 4.59%%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CNTA shares have gain 5.01% over the last week, with a monthly amount glided 1.40%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Centessa Pharmaceuticals plc ADR [NASDAQ: CNTA] stock has seen the most recent analyst activity on May 28, 2025, when Needham initiated its Buy rating and assigned the stock a price target of $35. Previously, Chardan Capital Markets started tracking the stock with Buy rating on May 08, 2025, and set its price target to $30. On March 31, 2025, Piper Sandler initiated with a Overweight rating and assigned a price target of $38 on the stock. TD Cowen started tracking the stock assigning a Buy rating. Morgan Stanley upgraded its rating to a Overweight and raised its price target to $26 on September 20, 2024. B. Riley Securities started tracking with a Buy rating for this stock on September 19, 2024, and assigned it a price target of $33. In a note dated July 18, 2024, Oppenheimer initiated an Outperform rating and provided a target price of $14 on this stock.
Centessa Pharmaceuticals plc ADR experienced fluctuations in its stock price throughout the past year between $8.46 and $19.09. Currently, Wall Street analysts expect the stock to reach $21 within the next 12 months. Centessa Pharmaceuticals plc ADR [NASDAQ: CNTA] shares were valued at $13.0 at the most recent close of the market. An investor can expect a potential return of 61.54% based on the average CNTA price forecast.
Analyzing the CNTA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.42, Equity is -0.57 and Total Capital is -0.39. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 12.57 points at the first support level, and at 12.14 for the second support level. However, for the 1st resistance point, the stock is sitting at 13.25, and for the 2nd resistance point, it is at 13.49.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Centessa Pharmaceuticals plc ADR [NASDAQ:CNTA] is 14.37. Further, the Quick Ratio stands at 14.37, while the Cash Ratio is 4.34. Considering the valuation of this stock, the price to sales ratio is 115.29, the price to book ratio is 4.50.
Transactions by insiders
Recent insider trading involved SAHA SAURABH, Chief Executive Officer, that happened on Jun 20 ’25 when 55000.0 shares were sold. Officer, CHAO DAVID M completed a deal on Jun 20 ’25 to buy 10000.0 shares. Meanwhile, Officer SAHA SAURABH bought 55000.0 shares on Jun 20 ’25.
